56 Views | 40 Downloads
Sirano Dhe-Paganon, Phone: 416-946-3876, Fax: 416-946-0588, sirano.dhepaganon@utoronto.ca
GVA and SX purified, inhibited, and crystallized USP5; JRW solved and refined the structure; AA conducted the nUBP pulldown studies; UBN conducted the Helix-Loop pulldown studies; AAH and GVA conducted the kinetic assay studies; XF, XZ, UBN, and YXW conducted the SAXS experiments; SDP, GVA, and JRW developed the experimental design, interpreted results and wrote the manuscript.
Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357 and under the Partner User Proposal PUP No. 22978. We thank Drs. S. Seifert and R.E. Winans (BESSRC, sector 12-ID) at Argonne National Laboratory for their support for synchrotron experiments.
The authors declare that they have no conflict of interest.
The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. Y-X Wang and X. Fang are supported by the Intramural Research funds of the National Cancer Institute, National Institutes of Health, Department of the Human Health Service, USA.